7 Related NICE guidance
-
Infliximab for the treatment of adults with psoriasis. NICE technology appraisal guidance 134 (2008).
-
Adalimumab for the treatment of psoriatic arthritis. NICE technology appraisal guidance 125 (2007). [Replaced by NICE technology appraisal guidance 199]
-
Etanercept and infliximab for the treatment of adults with psoriatic arthritis. NICE technology appraisal guidance 104 (2006). [Replaced by NICE technology appraisal guidance 199]
-
Etanercept and efalizumab for the treatment of adults with psoriasis. NICE technology appraisal guidance 103 (2006).